Avarieux
back to explore
Adial Pharmaceuticals Inc logo

ADIL

Adial Pharmaceuticals Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2018-07-27
$6.66
+0.34 (+5.38%)
last quote
Want the full multi-source brief on ADIL?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$6.66
High
$6.80
Low
$6.25
Previous close
$6.32
Fundamentals
Market cap
$17.13M
P/E (TTM)
—
P/S (TTM)
—
P/B
1.11x
Gross margin
—
Operating margin
—
Net margin
—
Rev growth (YoY)
—
EPS growth (YoY)
—
ROE
-1693.21%
52W high
$249.81
52W low
$1.31
Beta
-379.65x
Industry peers
by market cap
LPCN+2.76%RKTO-0.09%CTXR+3.88%ANEB+30.00%HIND+2.29%QCLS-1.57%CALC+4.76%AYR.A.CN
Upcoming earnings
next 30 days
2026-11-11in 67 days
Q3 2026EPS est $-0.68
Recent SEC filings
CIK 1513525filing-language history →
S-32026-08-28
694 KB
S-82026-08-28
396 KB
8-K2026-08-25reports 2026-08-19
184 KB
ARS2026-08-24reports 2025-12-31
1,345 KB
DEF 14A2026-08-24reports 2026-09-17
28,715 KB
8-K2026-08-21reports 2026-08-18
191 KB
Recent news
2026-08-28 → 2026-09-04
Benzinga · 6d
Adial Pharmaceuticals Files Prospectus Related To The Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders
-SEC Filing
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial